chrisvoncsefalvay/vaers-outcomes huggingface dataset:
6 weeks after the vaccine, I began to shiver out of the blue.  I could not shivering no matter how many blankets I put on.  I was also dizzy when walking.  I went to the emergency room.  They were not sure if I had an infection and could never articulate where or what may have caused my low grade fever.  They treated me with antibiotics and I felt better but even my primary care doctor claimed she did not know what caused my issue and questioned if I even had an infection.  This sort of event has never occurred unless I was actually sick or had the flu.  I had no other symptoms....no headaches, no breathing issues, no congestion, no sore throat, no body aches.  After 4 days I was released.   After personally hearing of people with chills in various body parts, arms and hands, it did not seem so unreasonable that this may have been MY reaction to the vaccine.  My only immediate reaction to the shot was a flushing feeling in my chest as if it were dry and tight but that passed in about 15 minutes or so.   But ending up in the hospital for no apparent reason makes me wonder?  They tested me for Covid and I did not test positive.
Decrease appetite / Black stools / Lethargy / Distended abdomen. Sent to ER. Dx: Intussusception.
In error: Administered 0.1 ml Td ID instead of PPD. Left forearm 20 mm x 20 mm erythema 10 mm induration.
Info has been received from an RN concerning an 8 year old male pt reported as a healthy child, who on 11/7/97 was vaccinated with varicella virus vaccine live. Beginning on 5/4/05, the pt experienced chickenpox. There was less than 50 lesions scattered on his face, neck and trunk. It was noted that he was afebrile and was provided symptomatic treatment. At the time of this report, the pt's outcome was not recovered. There was no product quality complaint reported. Unspecified medical treatment was sought by the pt. Additional info has been requested.
Pt was fasting at time of immunizations. Immediately after getting shots pt. turned white and passed out. She slid to the floor from her chair. Doctor and mom helped pt off the floor and was laid on the table within 15 seconds. SPO2 was 99% HR was 130 BP after 5-6 mins. came  from 88/60 to 106/72. She drank apple juice. Syncope lasted 20-30 seconds.
Myalgia. skin rash, acute renal failure & BLE edema. Acetaminophen.
Redness and itching at injection site.  Started 7 days after vaccination; worsened over next day becoming a circle measuring 7 cm top to bottom by 7 cm side to side (8th day); stayed the same for 1 day (9th day); began improving  on the 10th day; almost gone by the 12th day (04/19/2021).
Patient had shoulder pain that began immediately after vaccine administration - lasted at least until 12/18/2018 and possibly longer although records are not available. Vaccination site was confirmed and the clinic believes that administration was correct.
patient received 1st shingrix vaccine on 11/23/20. Per database, Pt also received a pneumococcal vaccine a week prior(11/17/20)to shingrix shot. No adverse events was reported to pharmacy until 6/3/21. Patient also received both covid shots since then(02/212-03/21) Per patient, he has been unable to lift his arm over his head since getting his shingrix shot. Patient stated he has been to a couple physical therapy visits so far and has had a $250- X-ray done.
After my 1st vaccination I was nauseous for the 2 days immediately after my vaccination; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 45 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 11Mar2021 14:30 (Lot number: ER8733) at the age of 44 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Reynaud's syndrome" (unspecified if ongoing); "hx of DVT" (unspecified if ongoing). There were no concomitant medications. The following information was reported: NAUSEA (non-serious) with onset Mar2021, outcome "recovered", described as "After my 1st vaccination I was nauseous for the 2 days immediately after my vaccination". Therapeutic measures were not taken as a result of nausea. Additional information: the patient did not take other vaccine in four weeks nor other medications in two weeks. The patient was nauseous for the 2 days immediately after her first vaccination. The patient had no COVID prior vaccination and was not tested post vaccination.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021488765 same patient/drug, diff dose/event
Full body hives , head, torso, legs arms.  Redness, hives, itchiness.   Mild constricted breathing.  Duration of severe symptoms 2-3 hrs.  2 Benadryl and sleep.  Morning residual mild  hives  resolved after a couple of hours.
I have recently been diagnosed with multiple sclerosis with no family history of it; This is a spontaneous report from a contactable consumer (patient). A 19-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in right arm on 06May2021 (Batch/Lot Number: FW0153) (at the age of 19-years-old) as dose 2, single for COVID-19 immunisation. Medical history included COVID-19 prior to vaccination. The patient's concomitant medications were not reported. The patient was previously administered with first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EW0171), administered in the right arm on 15Apr2021 (at the age of 19-years-old) for COVID-19 immunisation. On 02Jul2021, the patient reported that she was recently been diagnosed with multiple sclerosis with no family history of it. The event resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care visit. The patient was hospitalized for 4 days on an unspecified date due to the event. The patient was given steroids as treatment for the event. The patient underwent lab tests and procedures which included nasal swab post vaccination: negative on an unspecified date. Outcome of event was recovered with sequel in 2021.
Really bad chills, migraine, fatigue. I feels like I have a flu really bad. Arm sore down to my hand, all the way into my shoulder. The chills and head ache are horrible, I feel so sick
stiff arm; red; swollen; felt weak; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (stiff arm), ERYTHEMA (red), PERIPHERAL SWELLING (swollen) and ASTHENIA (felt weak) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-May-2021, the patient experienced LIMB DISCOMFORT (stiff arm), ERYTHEMA (red), PERIPHERAL SWELLING (swollen) and ASTHENIA (felt weak). At the time of the report, LIMB DISCOMFORT (stiff arm), ERYTHEMA (red), PERIPHERAL SWELLING (swollen) and ASTHENIA (felt weak) had resolved.            Concomitant medications was not reported.  Treatment medications was not reported.   This case was linked to MOD-2021-169811 (Patient Link).   Reporter did not allow further contact
Zostavax administered on 8/10/2009 without difficulty.  On 8/14 broke out with herpes zoster severe involvment on left side T5-T9 dermatomal pattern
Mild fatigue morning following injection, temperature 100.2 Fahrenheit measured at 4 pm
booster dose; body was more swollen; it hurt to squeezer her arm against her body; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP) from medical information team. The reporter is the parent.  A 17-year-old female patient received bnt162b2 (BNT162B2), administered in arm (Batch/Lot number: unknown) at the age of 17 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), for COVID-19 Immunization, reaction(s): "No adverse event "; Bnt162b2 (Dose no:2), for COVID-19 Immunization, reaction(s): "No adverse event ". The following information was reported: IMMUNISATION (non-serious), outcome "unknown", described as "booster dose"; PERIPHERAL SWELLING (non-serious), outcome "unknown", described as "body was more swollen"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "it hurt to squeezer her arm against her body".  Additional information: Caller advised patient to take ibuprofen. Caller reports that today after school it is still swollen but only hurts a little when she pushes her arm against her body.   This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
No additional AE etails; improper storage of product in use; This spontaneous report was received from Other Health Professional and refers to a 4-year-old male patient. Information regarding the patient's pertinent medical history, historical drugs, concurrent conditions, concomitant therapies, and previous drug reactions or allergies was not reported.  On 26-APR-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot #U025790, expiration date: 19-AUG-2023, administered subcutaneously for prophylaxis (strength was not provided).  The temperature excursion occurred on 23-MAR-2022, the vaccine was stored in a temperature of -14 degree Celsius (C) up to 10 C  for 3 hours; -10 C up to 8 C for 1 hour 30 minutes as recorded by a data logger. There was no previous temperature excursion reported. No additional adverse event details.
Hives, took Benadryl they went away. Fever, chills then really hot, super achy. This happened on Saturdat around 515 then Sunday super achy, very tired, couldnt function or move. Monday still very achy still had fever. Tuesday felt better
Fever, aches, joint pain developed within 9 hours.  Fever broke during the night.  R underarm lymph nodes swollen (palpable) & tender 3 days.  36 hours after vaccine noted 2" reddened circular area near armpit.  All symptoms resolved 4 days post injection.  No treatment sought.
pt rec'd a flu shot at his job.  the next day he felt very ill. He was noted to have a diffuse rash on posterior palate with individual white vesicles/comedones on erythematous bases.
Around 12 hours after I experienced intense flu like symptoms (including chills, headache, nausea, fever, muscle aches) that persisted for over 24 hours. As of 4/10 I am still having mild effects
No further AE/PQC reported.; received a dose of GARDASIL 9 too soon. Caller reports that the patient received the first dose of GARDASIL 9 on 27 Aug 2020 and the secood dose 10 Sep 2020; This spontaneous report as received from an office manager refers to a 24-year-old female patient. No information regarding the patient's pertinent medical history, concomitant medications, drug reactions and allergies was provided.  On 27-AUG-2020, the patient was vaccinated with a first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, 0.5 milliliter, intramuscularly (lot number and expiration date were not provided); on 10-SEP-2020 (also reported as too soon), she received the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, 0.5 milliliter, intramuscularly (lot number and expiration date were not provided), both as prophylaxis. No adverse effect was reported.
This is a spontaneous report from a contactable consumer (patient). A 77-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6200), via an unspecified route of administration, administered in Arm Left on 13Feb2021 11:30 at 77 years old as 2nd dose, single for COVID-19 immunization. Medical history included hypertension from an unknown date. No medications received within 2 weeks of vaccination. No other vaccine received within 4 weeks of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. The patient received the first dose BNT162B2 on an unspecified date (lot number: EN6200) for COVID-19 immunization on the left arm. On 14Apr2021, it was reported that patient had lost energy to get out of bed. Patient was transported to the emergency room with fevers and altered mental status. The patient was admitted in the hospital for 6 days from 14Apr2021 to 20Apr2021. The reporter considered the events to have caused disability. The patient received an unspecified treatment. Multiple tests were done to the patient on an unspecified date with unknown result. The patient had a COVID-19 test post vaccination via nasal swab on 15Apr2021 with a negative result. The outcome of the events was recovering.
The shot was fine that evening, but the next day I had the sore arm as expected. I had flu-like symptoms and my eyes were scratchy. The next day I felt much better, but my eyes were still scratchy. On Monday progressively through the day my eyes started to hurt, and any type of light made my eyes hurt badly and the whites of my eyes were red and swollen. I called my doctor the next morning and had a friend take me and the Doctor came in and closed the blinds and said I had inflammation of mucous membrane of the eyes and the only thing they heard of to fix it was to take the same medicine for conjunctivitis. I did that and within two days my eyes were fine. By Thursday, the lights weren't affecting my eyes and it went away. I just found out I have cataracts in April. I think cataracts were before vaccine.
Fatigue; feverish till upto 2 weeks; Shooting pain behind head; seems like a pinched nerve; Body ache; chills that doesn't seem to go away more than 1.5 weeks after the shot; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 05Jun2021 15:00 (Batch/Lot number: unknown) at the age of 42 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "High Blood pressure" (unspecified if ongoing); "Low iron" (unspecified if ongoing). Concomitant medication(s) included: AMLODIPINE; VITAMIN D [VITAMIN D NOS]. Vaccination history included: Bnt162b2 (product=COVID 19, Brand: Pfizer, Lot unknown: True, Lot unknown reason: Unable to locate or read the details, Administration date= 15May2021, Administration time: 03:00 PM, Dose number=1, Vaccine location= Left arm, Route of administration: Intramuscular), administration date: 15May2021, when the patient was 42 years old, for Covid-19 immunisation. The following information was reported: FATIGUE (non-serious) with onset 06Jun2021 11:00, outcome "recovered", described as "Fatigue"; PYREXIA (non-serious) with onset 06Jun2021 11:00, outcome "recovered", described as "feverish till upto 2 weeks"; HEADACHE (non-serious) with onset 06Jun2021 11:00, outcome "recovered", described as "Shooting pain behind head"; NERVE COMPRESSION (non-serious) with onset 06Jun2021 11:00, outcome "recovered", described as "seems like a pinched nerve"; PAIN (non-serious) with onset 06Jun2021 11:00, outcome "recovered", described as "Body ache"; CHILLS (non-serious) with onset 06Jun2021 11:00, outcome "recovered", described as "chills that doesn't seem to go away more than 1.5 weeks after the shot". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of fatigue, pyrexia, headache, nerve compression, pain, chills.  Additional Information: Patient did not have other vaccine in four weeks. Other medications in two weeks were Amlodipine, Vitamin D. Adverse Event: Fatigue, feverish till up to 2 weeks. Shooting pain behind head, seems like a pinched nerve. Body ache, chills that doesn't seem to go away more than 1.5 weeks after the shot. Patient did not have covid prior vaccination. Patient was not tested covid post vaccination. It was not known if patient had known allergies. Prior Vaccinations (within 4 weeks) reported as none. Patient's Medical History (including any illness at time of vaccination) reported as none. Relevant Tests reported as none. The seriousness criteria were reported as not serious. Patient did not received treatment for AEs.  Follow-up attempts completed. No further information is expected.
pt recv vax 20JAN97 & the same day pt exp some itching on rt deltoid muscle;21JAN97 pt devel an itchy papular urticaria rash over a 3cm area of the rt deltoid clearly @ the site of inj;23JAN97 pt recovered;
Redness, swelling at injection site 12 x 16 cm.  Treatment: Ice packs, Tylenol as needed.
moderately severe, persistent tinnitus, not resolving, began approximately 1 week after receiving the vaccination. No other exposures different from routine, no previous hx of tinnitus, no aural trauma or exposure to excessive noise, no explicable cause of tinnitus other than recent vaccine exposure. Was not present or observed after first dose, but began after second dose and has persisted to this date, approximately 1 month after receiving second dose.
This spontaneous report was received from a currently 72-year-old female patient with no concurrent conditions, and drug reactions or allergies. The medical history include that she was in a "great health ". It was reported that the patient took unspecified medications as concomitant therapies. On 18-JUN-2015, the patient was vaccinated with a dose of ZOSTAVAX (strength, dose, frequency, route of administration, anatomical location, lot number, and expiration date were not provided) for prophylaxis. On 05-MAR-2017, the patient developed shingles, and then, on the same date, the patient was hospitalized due to chest pains and muscle spasms. Subsequently, on 06-MAR-2017, the patient was discharged from the hospital and later, approximately in March 2017, the patient developed a rash which spread from the front of her chest to her back, and which was painful in the locations it was. On an unknown date, the patient sought unspecified medical attention and consequently, some unspecified laboratory test and diagnostic procedures were performed (results not provided). The patient was treated with unspecified pain medications which made her nauseous, and without which, she would not be able "to function, walk or breathe"; but given that it upset her stomach, on an unspecified date in 2017, she had to start to cut down. The patient stated that before she was in great health, but now it hurts to put clothes on and she had a post herpetic neuralgia, therefore, she wanted to see a pain specialist to assist her. At the time of reporting, the patient did not recover from the adverse events. The causal relationship between the adverse events and the therapy with ZOSTAVAX was not reported. No product quality complaint was involved. Additional information has been requested.
Patient reported localized pain in knee area of right leg while walking, about 30 minutes after vaccination.  Patient described pain as feeling similar to pain from bruising and also noted it as a sharp pain. No fever, difficulty breathing, or any other events were reported.
I got a headache, queasy stomach and tired.  12 hours after shot.  Improving after 14 hours of first symptom
This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date and BUD date was 28-Jan-2023), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 29-Dec-2022 and was administered on 10-Feb-2023) and NO ADVERSE EVENT (No adverse event) in a 94-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7172B) for COVID-19 prophylaxis.     No Medical History information was reported.       No concomitant information was reported.
Patient developed cellulitis in his left arm early morning the day after vaccination. He had redness and swelling and had to visit the hospital for ice, compression, and 2 rxs -- keflex and hydroxyzine.
1250PM sitting on floor; fell backwards, eyes rolled back, non responsive arched back lasted about 1 min; couldn't stand as arms & legs numb; 1PM sitting in dad's lap same occurance; took pt to MD put on APAP; 9JUL pt quiet, less active;
Neck pain b/l sides radiating upwards to the jaw, swollen PAINFUL cervical lymph nodes, Fatigue,
This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 60-year-old female patient who received SHINGRIX for prophylaxis. On 17th July 2018, the patient received SHINGRIX. On 17th July 2018, less than a day after receiving SHINGRIX, the patient experienced injection site erythema. On 18th July 2018, the patient experienced injection site pain. On an unknown date, the outcome of the injection site erythema and injection site pain were unknown. It was unknown if the reporter considered the injection site erythema and injection site pain to be related to SHINGRIX. Additional details were provided as follows: The patient was given the SHINGRIX in her upper arm, a day before the reporting date and noticed pinkish area around the site of the injection about 3 to 8 inches in diameter later that day. On the reporting date, 1 day after vaccination, the patient noticed a 2nd area about 1 to 2 inch below the injection site that was again pinkish but was more like an inch in diameter and very painful. She had a call into her physician's office. A product information (PI) was being sent to the patient.
This spontaneous case reported by a consumer, describes the occurrence of feeling abnormal (felt really bad) and illness (sick) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 038B21A) for COVID-19 immunization. No medical history reported. On Apr 18, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Apr 18, 2021, patient experienced feeling abnormal (felt really bad) and illness (sick). On Apr 20, 2021, feeling abnormal (felt really bad) and illness (sick) resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medication or treatment information provided.
Fever (ave about 102), body aches, chills, head ache, extreme pain and redness at injection site. Treated with 4x200mg ibuprofen every 4 hours. Symptoms tapered off about 72 hours later. As of 3:30 PM 05/15/2011, still have head ache, low fever, and some body aches. Some discomfort at injection site.
immed upon receiving vax pt cried & both legs turned red later in the day had intermittant screaming;
Shaking chill for 10 min x 1 time, headache for 1 day, lethargy for 1 day, neck pain for 1 day
expired vaccine adminsitered; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine adminsitered) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine adminsitered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired vaccine adminsitered) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported.   Reporter mentioned that a patient told that he received an expired booster dose of the Moderna Covid-19 Vaccine. The vaccine was expired for 5 days.  No treatment medications reported.